Braidwell’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Braidwell's CDNA Position: Q2 2026 in Review
Braidwell reduced its CareDx (CDNA) stake by 44% in Q2 2026, selling an estimated $20.7M and leaving 1,220,602 shares worth $34.8M. The position accounts for 1.29% of the portfolio, ranked #28.
Braidwell first reported a position in CDNA in Q3 2025 and has held it in 4 quarters since. The position peaked at $37.7M in Q1 2026. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Braidwell held 1,220,602 shares of CareDx worth $34.8M as of Q2 2026.
- Braidwell sold 952,544 CareDx shares in Q2 2026, an estimated $20.7M.
- CareDx made up 1.29% of Braidwell's portfolio in Q2 2026, its #28 holding.
- Braidwell first reported a position in CareDx in Q3 2025 and has held it in 4 quarters since.
- Braidwell's CareDx position peaked at $37.7M in Q1 2026.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.